If you need more lookups,
subscriptions start at $34 USD/month.
Bas Koster Location
Amsterdam, NH, NL
Bas Koster Work
Senior Medical Director Global Clinical Development (Hematology - Oncology) @ (October 2025 - Present)
Medical Director Global Clinical Development (Hematology - Oncology) @ (January 2022 - October 2025)
Director Medical Strategy and Innovation - International Markets @ (May 2021 - January 2022)
Global Medical Officer Oncology @ (November 2019 - January 2022)
Medical Director - Benelux @ (November 2019 - April 2021)
Visiting Research Fellow @ (November 2019 - October 2020)
Principal Investigator Medical Oncology (Immunotherapy) @ (April 2017 - November 2019)
Physician-Scientist Medical Oncology (Immunotherapy) @ (September 2011 - April 2017)
Global Medical Director, RPPV @ myTomorrows (June 2016 - April 2017)
Director Medical Affairs - EMEA @ Agendia (June 2015 - May 2016)
Research Coordinator and Program Coordinator @ (January 2013 - January 2015)
Bas Koster Education
Vrije Universiteit Amsterdam (VU Amsterdam)
Doctor of Medicine (M.D.) (Medicine)
2009-2012
Vrije Universiteit Amsterdam (VU Amsterdam)
Bachelor of Science (B.Sc.) (Medicine)
2005-2008
Vrije Universiteit Amsterdam (VU Amsterdam)
Doctor of Philosophy - Ph.D (Cancer Immunotherapy)
2020
Bas Koster Skills
Clinical Research
Clinical Trials
Healthcare
Hospitals
Medicine
Public Speaking
Research
Treatment
Bas Koster Summary
Bas Koster, based in Amsterdam, NH, NL, is currently a Senior Medical Director Global Clinical Development (Hematology - Oncology) at Johnson & Johnson Innovative Medicine. Bas Koster brings experience from previous roles at Johnson & Johnson Innovative Medicine and Philips. Bas Koster holds a 2009 - 2012 Doctor of Medicine (M.D.) in Medicine @ Vrije Universiteit Amsterdam (VU Amsterdam). With a robust skill set that includes Clinical Research, Clinical Trials, Healthcare, Hospitals, Medicine and more. Bas Koster has 2 emails on RocketReach.
Looking for a different Bas Koster?
Find contact details for 700 million professionals.